Effects of add on PTH(1-84) substitution therapy in hypoparathyroidism: Results from a double-blind randomised controlled study

被引：0
|
作者：
Sikjaer, T. T. [1 ]
Rejnmark, L. [1 ]
Mosekilde, L. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.109
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] PTH Substitution Therapy for Chronic Hypoparathyroidism: PTH 1-84 and Palopegteriparatide
    Palermo, Andrea
    Naciu, Anda Mihaela
    Donovan, Yu Kwang Tay
    Tabacco, Gaia
    Zavatta, Guido
    CURRENT OSTEOPOROSIS REPORTS, 2025, 23 (01)
  • [2] PTH(1-84) substitution therapy in hypoparathyroidism: Effects on muscle cells and muscle function
    Sikjaer, T.
    Rolighed, L.
    Rejnmark, L.
    Mosekilde, L.
    BONE, 2012, 50 : S177 - S177
  • [3] Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial
    Sikjaer, T.
    Rolighed, L.
    Hess, A.
    Fuglsang-Frederiksen, A.
    Mosekilde, L.
    Rejnmark, L.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (06) : 1717 - 1726
  • [4] PTH(1-84) replacement therapy for the treatment of hypoparathyroidism
    Cusano, Natalie E.
    Rubin, Mishaela R.
    Bilezikian, John P.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (01) : 5 - 13
  • [5] PTH (1-84) REPLACEMENT THERAPY IN HYPOPARATHYROIDISM: EFFECTS ON BONE METABOLISM AND STRUCTURE
    Sikjaer, Tanja
    Rejnmark, Lars
    Thomsen, Jesper S.
    Bruel, Annemarie
    Mosekilde, Leif
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S255 - S256
  • [6] Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study
    Mannstadt, Michael
    Clarke, Bart L.
    Vokes, Tamara
    Brandi, Maria Luisa
    Ranganath, Lakshminarayan
    Fraser, William D.
    Lakatos, Peter
    Bajnok, Laszlo
    Garceau, Roger
    Mosekilde, Leif
    Lagast, Hjalmar
    Shoback, Dolores
    Bilezikian, John P.
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (04): : 275 - 283
  • [7] Effects of Long Term PTH(1-84) Replacement Therapy in Hypoparathyroidism and the Consequence of Termination of Therapy
    Sikjaer, Tanja
    Rolighed, Lars
    Moser, Emil
    Mosekilde, Leif
    Rejnmark, Lars
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [8] Effects of PTH(1–84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial
    T. Sikjaer
    L. Rolighed
    A. Hess
    A. Fuglsang-Frederiksen
    L. Mosekilde
    L. Rejnmark
    Osteoporosis International, 2014, 25 : 1717 - 1726
  • [9] PTH(1-84) Replacement Therapy in Hypoparathyroidism: A Randomized Controlled Trial on Pharmacokinetic and Dynamic Effects After 6 Months of Treatment
    Sikjaer, Tanja
    Amstrup, Anne Kristine
    Rolighed, Lars
    Kjaer, Soren Geill
    Mosekilde, Leif
    Rejnmark, Lars
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (10) : 2232 - 2243
  • [10] The Effect of Adding PTH(1-84) to Conventional Treatment of Hypoparathyroidism: A Randomized, Placebo-Controlled Study
    Sikjaer, Tanja
    Rejnmark, Lars
    Rolighed, Lars
    Heickendorff, Lene
    Mosekilde, Leif
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (10) : 2358 - 2370
12345